Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanna Probiotics is a biotechnology company based in Thailand that focuses on the isolation, characterization, and commercialization of probiotic microorganisms. The company utilizes indigenous microbial strains from Northern Thailand to develop functional food ingredients and health supplements aimed at improving gut health and immunity. As a specialized CDMO, Lanna Probiotics provides end-to-end services including strain selection, fermentation optimization, and OEM manufacturing for the global nutraceutical market. Their research-driven approach is supported by collaborations with leading academic institutions to ensure the efficacy and safety of their microbial products. The company serves both the human health and animal nutrition sectors through its proprietary probiotic cultures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanna Probiotic Company.